J.P. Marvel Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.83M | Buy |
|
|||||
|
2025
Q2 | $5.62M | Sell |
|
|||||
|
2025
Q1 | $5.63M | Sell |
|
|||||
|
2024
Q4 | $6.94M | Sell |
|
|||||
|
2024
Q3 | $7.77M | Sell |
|
|||||
|
2024
Q2 | $8.15M | Sell |
|
|||||
|
2024
Q1 | $10.7M | Buy |
|
|||||
|
2023
Q4 | $9.17M | Sell |
|
|||||
|
2023
Q3 | $7.6M | Hold |
|
|||||
|
2023
Q2 | $8.16M | Buy |
|
|||||
|
2023
Q1 | $7.35M | Buy |
|
|||||
|
2022
Q4 | $7.91M | Hold |
|
|||||
|
2022
Q3 | $7.15M | Sell |
|
|||||
|
2022
Q2 | $7.77M | Hold |
|
|||||
|
2022
Q1 | $10.3M | Buy |
|
|||||
|
2021
Q4 | $13.5M | Buy |
|
|||||
|
2021
Q3 | $14.6M | Buy |
|
|||||
|
2021
Q2 | $13.1M | Buy |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $8.32M | Buy |
|
|||||
|
2020
Q3 | $7.52M | Buy |
|
|||||
|
2020
Q2 | $5.78M | Buy |
|
|||||
|
2020
Q1 | $4.17M | Buy |
|
|||||
|
2019
Q4 | $4.83M | Hold |
|
|||||
|
2019
Q3 | $4.19M | Buy |
|
|||||
|
2019
Q1 | $4.22M | Buy |
|
|||||
|
2018
Q4 | $2.44M | Buy |
|
|||||
|
2018
Q2 | $1.76M | Hold |
|
|||||
|
2018
Q1 | $1.68M | Hold |
|
|||||
|
2017
Q4 | $1.72M | Hold |
|
|||||
|
2017
Q3 | $1.7M | Sell |
|
|||||
|
2017
Q2 | $1.59M | Sell |
|
|||||
|
2017
Q1 | $1.42M | Sell |
|
|||||
|
2016
Q4 | $1.34M | Buy |
|
|||||
|
2016
Q3 | $1.22M | Buy |
|
|||||
|
2016
Q2 | $1.17M | Buy |
|